Annual Gross Profit
-$322.59 M
-$176.37 M-120.61%
31 December 2023
Summary:
Cytokinetics Incorporated annual gross profit is currently -$322.59 million, with the most recent change of -$176.37 million (-120.61%) on 31 December 2023. During the last 3 years, it has fallen by -$281.47 million (-684.46%). CYTK annual gross profit is now -495.64% below its all-time high of $81.54 million, reached on 31 December 2009.CYTK Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
-$84.15 M
-$4.80 M-6.05%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly gross profit is currently -$84.15 million, with the most recent change of -$4.80 million (-6.05%) on 30 September 2024. Over the past year, it has dropped by -$2.00 million (-2.43%). CYTK quarterly gross profit is now -216.99% below its all-time high of $71.93 million, reached on 30 June 2009.CYTK Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
-$327.54 M
-$2.00 M-0.61%
30 September 2024
Summary:
Cytokinetics Incorporated TTM gross profit is currently -$327.54 million, with the most recent change of -$2.00 million (-0.61%) on 30 September 2024. Over the past year, it has dropped by -$15.19 million (-4.86%). CYTK TTM gross profit is now -501.70% below its all-time high of $81.54 million, reached on 31 December 2009.CYTK TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -120.6% | -2.4% | -4.9% |
| 3 y3 years | -684.5% | -95.7% | -163.9% |
| 5 y5 years | -459.7% | -493.7% | -445.6% |
CYTK Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -684.5% | at low | -364.3% | at low | -647.1% | +0.3% |
| 5 y | 5 years | -684.5% | at low | -364.3% | at low | -931.7% | +0.3% |
| alltime | all time | -495.6% | at low | -217.0% | at low | -501.7% | +0.3% |
Cytokinetics Incorporated Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$84.15 M(+6.1%) | -$327.54 M(+0.6%) |
| June 2024 | - | -$79.35 M(-1.7%) | -$325.54 M(-0.9%) |
| Mar 2024 | - | -$80.73 M(-3.1%) | -$328.52 M(+1.8%) |
| Dec 2023 | -$322.59 M(+120.6%) | -$83.30 M(+1.4%) | -$322.59 M(+3.3%) |
| Sept 2023 | - | -$82.15 M(-0.2%) | -$312.35 M(+7.6%) |
| June 2023 | - | -$82.33 M(+10.1%) | -$290.42 M(+64.8%) |
| Mar 2023 | - | -$74.81 M(+2.4%) | -$176.25 M(+20.5%) |
| Dec 2022 | -$146.22 M(+63.4%) | -$73.06 M(+21.3%) | -$146.22 M(+139.5%) |
| Sept 2022 | - | -$60.22 M(-289.1%) | -$61.06 M(+39.3%) |
| June 2022 | - | $31.84 M(-171.1%) | -$43.84 M(-59.9%) |
| Mar 2022 | - | -$44.79 M(-470.1%) | -$109.28 M(+22.1%) |
| Dec 2021 | -$89.51 M(+117.7%) | $12.10 M(-128.1%) | -$89.51 M(-27.9%) |
| Sept 2021 | - | -$43.00 M(+28.0%) | -$124.11 M(+95.1%) |
| June 2021 | - | -$33.60 M(+34.3%) | -$63.63 M(+31.9%) |
| Mar 2021 | - | -$25.01 M(+11.2%) | -$48.22 M(+17.3%) |
| Dec 2020 | -$41.12 M(-30.6%) | -$22.50 M(-228.7%) | -$41.12 M(+29.5%) |
| Sept 2020 | - | $17.49 M(-196.1%) | -$31.75 M(-49.9%) |
| June 2020 | - | -$18.20 M(+1.6%) | -$63.41 M(+2.1%) |
| Mar 2020 | - | -$17.91 M(+36.5%) | -$62.09 M(+4.8%) |
| Dec 2019 | -$59.26 M(+2.8%) | -$13.12 M(-7.4%) | -$59.26 M(-1.3%) |
| Sept 2019 | - | -$14.17 M(-16.0%) | -$60.03 M(+6.0%) |
| June 2019 | - | -$16.88 M(+11.9%) | -$56.61 M(+2.7%) |
| Mar 2019 | - | -$15.08 M(+8.5%) | -$55.10 M(-3.1%) |
| Dec 2018 | -$57.63 M(-25.1%) | -$13.90 M(+29.3%) | -$56.88 M(-17.9%) |
| Sept 2018 | - | -$10.75 M(-30.0%) | -$69.25 M(-10.4%) |
| June 2018 | - | -$15.37 M(-8.9%) | -$77.27 M(-1.8%) |
| Mar 2018 | - | -$16.87 M(-35.8%) | -$78.66 M(+2.3%) |
| Dec 2017 | -$76.93 M(-265.4%) | -$26.27 M(+40.0%) | -$76.93 M(+111.9%) |
| Sept 2017 | - | -$18.77 M(+12.0%) | -$36.30 M(-253.5%) |
| June 2017 | - | -$16.76 M(+10.7%) | $23.65 M(-35.2%) |
| Mar 2017 | - | -$15.14 M(-205.4%) | $36.49 M(-21.6%) |
| Dec 2016 | $46.51 M | $14.36 M(-65.1%) | $46.51 M(+62.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $41.18 M(-1150.3%) | $28.66 M(-277.6%) |
| June 2016 | - | -$3.92 M(-23.3%) | -$16.14 M(-11.9%) |
| Mar 2016 | - | -$5.11 M(+46.4%) | -$18.31 M(+3.2%) |
| Dec 2015 | -$17.74 M(-805.6%) | -$3.49 M(-3.3%) | -$17.74 M(+1298.0%) |
| Sept 2015 | - | -$3.61 M(-40.7%) | -$1.27 M(-475.4%) |
| June 2015 | - | -$6.09 M(+34.2%) | $338.00 K(-86.4%) |
| Mar 2015 | - | -$4.54 M(-135.0%) | $2.48 M(-1.2%) |
| Dec 2014 | $2.51 M(-113.4%) | $12.98 M(-747.3%) | $2.51 M(+4090.0%) |
| Sept 2014 | - | -$2.00 M(-49.2%) | $60.00 K(-100.9%) |
| June 2014 | - | -$3.95 M(-12.5%) | -$6.91 M(-51.7%) |
| Mar 2014 | - | -$4.51 M(-142.9%) | -$14.30 M(-23.9%) |
| Dec 2013 | -$18.80 M(-33.1%) | $10.53 M(-217.3%) | -$18.80 M(-49.2%) |
| Sept 2013 | - | -$8.98 M(-20.8%) | -$37.00 M(+5.4%) |
| June 2013 | - | -$11.34 M(+25.8%) | -$35.11 M(+16.4%) |
| Mar 2013 | - | -$9.01 M(+17.4%) | -$30.17 M(+7.4%) |
| Dec 2012 | -$28.08 M(-15.4%) | -$7.67 M(+8.3%) | -$28.08 M(-50.6%) |
| Sept 2012 | - | -$7.08 M(+10.7%) | -$56.84 M(+17.6%) |
| June 2012 | - | -$6.40 M(-7.6%) | -$48.32 M(+18.2%) |
| Mar 2012 | - | -$6.92 M(-81.0%) | -$40.87 M(+23.2%) |
| Dec 2011 | -$33.18 M(-6.4%) | -$36.42 M(-2652.6%) | -$33.18 M(-1.5%) |
| Sept 2011 | - | $1.43 M(+35.5%) | -$33.67 M(-3.0%) |
| June 2011 | - | $1.05 M(+38.0%) | -$34.70 M(-1.7%) |
| Mar 2011 | - | $763.00 K(-102.1%) | -$35.30 M(-0.4%) |
| Dec 2010 | -$35.44 M(-143.5%) | -$36.91 M(-9469.0%) | -$35.44 M(-1517.5%) |
| Sept 2010 | - | $394.00 K(-14.7%) | $2.50 M(-67.2%) |
| June 2010 | - | $462.00 K(-25.6%) | $7.61 M(-90.4%) |
| Mar 2010 | - | $621.00 K(-39.3%) | $79.08 M(-3.0%) |
| Dec 2009 | $81.54 M(+556.5%) | $1.02 M(-81.4%) | $81.54 M(+1.3%) |
| Sept 2009 | - | $5.51 M(-92.3%) | $80.51 M(+7.3%) |
| June 2009 | - | $71.93 M(+2236.9%) | $75.01 M(+1119.2%) |
| Mar 2009 | - | $3.08 M(+0.1%) | $6.15 M(+100.1%) |
| Dec 2008 | $12.42 M | - | - |
| June 2008 | - | $3.07 M | $3.07 M |
FAQ
- What is Cytokinetics Incorporated annual gross profit?
- What is the all time high annual gross profit for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual gross profit year-on-year change?
- What is Cytokinetics Incorporated quarterly gross profit?
- What is the all time high quarterly gross profit for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly gross profit year-on-year change?
- What is Cytokinetics Incorporated TTM gross profit?
- What is the all time high TTM gross profit for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM gross profit year-on-year change?
What is Cytokinetics Incorporated annual gross profit?
The current annual gross profit of CYTK is -$322.59 M
What is the all time high annual gross profit for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual gross profit is $81.54 M
What is Cytokinetics Incorporated annual gross profit year-on-year change?
Over the past year, CYTK annual gross profit has changed by -$176.37 M (-120.61%)
What is Cytokinetics Incorporated quarterly gross profit?
The current quarterly gross profit of CYTK is -$84.15 M
What is the all time high quarterly gross profit for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly gross profit is $71.93 M
What is Cytokinetics Incorporated quarterly gross profit year-on-year change?
Over the past year, CYTK quarterly gross profit has changed by -$2.00 M (-2.43%)
What is Cytokinetics Incorporated TTM gross profit?
The current TTM gross profit of CYTK is -$327.54 M
What is the all time high TTM gross profit for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM gross profit is $81.54 M
What is Cytokinetics Incorporated TTM gross profit year-on-year change?
Over the past year, CYTK TTM gross profit has changed by -$15.19 M (-4.86%)